ADHD pharmacology Flashcards
Boxed Warning Stimulants
Rx sudden cardiac death, not well proven
Methylphenidate
Stimulant
1) MOA: block NE & Dopamine reuptake
- possible effects on serotonergic dopamine receptors
2) once daily patch option
3) ER better to evade tolerance issues
NOT approves in ages < 6 yrs
FIRST LINE FOR CHILDREN
Bupropion
1) antidepressant
2) off label ADHD
Stimutlants
FIRST LINE TREATMENT ADHD, 90% response rate
Clonidine ER
Non-stimulant
1) MOA: alpha 2 receptor agonist, blocks NE release AND increased blood flow to prefrontal cortex
2) useful in pt. with ADHD AND aggressive behavior
3) AE: somnolence, bradycardia, sedative, dry mouth
4) 1-2 WEEK ONSET FOR EFFICACY
Dexamethylphenidate
Stimulant
1) D-entaniomer methylphenidine DOUBLE potency 2) MOA: Strong block dopamine NE reuptake 3) capsule form* easy to hide 4) not studied ages < 6 yrs
Lisdexamphetamine
Stimulant
1) MOA: block NE & dopamine reuptake
2) NOT active until first pass metabolism through liver
- PRODRUG dextroamphetamine
Nortriptyline
1) TCA
2) off label ADHD
Amitryptyline
1) TCA
2) off label use ADHD
Guanfacine ER
non-stimulant
1) MOA: central Alpha 2a receptor agonist
- more selective for receptor subtype than clonidine
2) less effect on BP
3) SE: somnolence, bradycardia, HOTN, sedative effect*
compiramine
1) SNRI
2) off label ADHD
Amoxetine
Non-stimulant
1) MOA: inhibit reuptake NE
2) PGx dosing (more accurate than wt.)
3) AE: somnolence, GI upset
4) no known abuse potential
5) 2-4 WEEKS FOR EFFECTS TO KICK IN*
6) BW
- increased rx suicide ideation
- liver damage-d/c if jaundice
7) CAUTION: Cv disease, cardiac abnormalities, HTN, tachycardia
Dextroamphetamine
Stimulant
1) MOA: greater affinity for dopamine receptor > NE receptor
- more potent form amphetamine
2) ER NOT for children ages < 6 years
3) IR for children 3-5 years
SE/Caustions stimulants
1) increased BP and HR
2) psychosis?
3) growth retardation?
4) dysphoria
5) HA
6) abdominal pain
7)abuse concern
IR/short acting> ER/long acting
Viloxazine
Non-stimulant
1) MOA: NE reuptake inhibitor and 5HT2 receptor effects
2) AE: somnolence, decreased appetite, N/V, insomnia, irritability
3) CYPIA2 inhibitor
-weak 2D6/3A4 inhibition
DRUG INTERACTIONS
4)BW*: Suicide Ideation risk
5) Monitor BP, HR